{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:18:52Z","timestamp":1790878732890,"version":"4.1.0"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":4808,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[1994,4]]},"abstract":"<jats:p>In the Leiden region, the cervical cancer screening programme for the age group 35\u201354 years shifted in 1989 from one in which the smears were taken by specially trained paramedical personnel in health centres to a programme where the general practitioner is the smear taker. Hence, it is possible to compare the results of the two types of screening to evaluate whether involvement of general practitioners leads to better uptake of screening. In the 6 year period evaluated in this paper, the 3\u2010yearly cytological rate per thousand for severe dysplasia or worse increased from 1.00 to 3.40; when stratified by age the positive rates were significantly higher. the histological rate per thousand for severe dysplasia increased from 0.60 to 2.09, and for carcinoma <jats:italic>in situ<\/jats:italic> from 0.35 to 1.36. All six invasive carcinomata were detected in the GP programme (0.31%). the general practitioner is clearly more able to attract the \u2018high\u2010risk\u2019groups.<\/jats:p><jats:p>Dans la re\u00e9ion de Leiden, le programme de d\u00e9pistage du cancer du col pour les tranches d'\u00e2ge de 35\u201354 ans a \u00e9t\u00e9 modifi\u00e9 en 1989. Le programme \u00e9tait initialement bas\u00e9 sur des frottis faits dans des centres de sant\u00e9, par un personnel param\u00e9dical ayant suivi une formation particuli\u00e8re. Apr\u00e8s 1989, le m\u00e9decin g\u00e9n\u00e9raliste est devenu le pr\u00e9leveur. II est done possible de comparer les r\u00e9sultats de ces 2 types de d\u00e9pistage et d'appr\u00e9cier si la participation des m\u00e9decins g\u00e9n\u00e9ralistes a pour cons\u00e9quence un meilleur d\u00e9pistage. Au cours de la p\u00e9riode d'\u00e9tude, les taux pour 1000 de positivit\u00e9 cytologique pour les l\u00e9sions graves (de type dysplasie s\u00e9v\u00e8re et plus) et par p\u00e9riode de 3 ans ont augment\u00e9 de 1,00 \u00e0 3,40. Lorsque l'on stratifie sur l'\u00e2ge, les taux de cas positifs sont significativement sup\u00e9rieurs. Le taux histologique des dysplasies s\u00e9v\u00e8res pour 1000 passe de 0,60 \u00e0 2,09 et celui du carcinome in situ de 0,35 \u00e0 1,36. Les 6 cas de carcinome invasif ont \u00e9t\u00e9 d\u00e9tect\u00e9s par le programme impliquant les m\u00e9decins g\u00e9n\u00e9ralistes (0,31%). II est clair que le m\u00e9decin g\u00e9n\u00e9raliste est mieux plac\u00e9 pour d\u00e9pister les patientes \u00e0\u201chaut risque\u201d.<\/jats:p><jats:p>Im Bezirk von Leiden wurden die Abstriche der 35\u2010 bis 54 j\u00e4hrigen vor 1989 von speziell ausgebildeten Hilfskr\u00e4ften in Gesundheitszentren hergestellt, w\u00e4hrend diese Aufgabe dann von den Allgemeinmedizinern \u00fcbernommen wurde. Dies erlaubt einen Vergleich zwische den Pr\u00e4paraten von zwei jeweils 3 Jahre umfassenden Perioden. Der Anteil schwerer Dysplasien und st\u00e4rkerer Ver\u00e4nderungen nahm von 1.00 auf 3.40 pro Tausend zu. Der histologische Anteil der schweren Dysplasien erh\u00f6hte sich von 0.60 auf 2.09 und der der Carcinomata in situ von 0.35 auf 1.36. Alle 6 nachgewiesenen invasiven Carcinome wurden in den Abstrichen der Allgemeinmediziner entdeckt (0.31%<jats:sub>o<\/jats:sub>). Damit ist klar, da\u00df die Allgemeinmediziner die Risikogruppen besser zu erfassen verm\u00f6gen.<\/jats:p>","DOI":"10.1111\/j.1365-2303.1994.tb00529.x","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T10:57:44Z","timestamp":1180609064000},"page":"69-75","source":"Crossref","is-referenced-by-count":6,"title":["Involving the General Practitioner In Screening For Cervical Cancer"],"prefix":"10.1111","volume":"5","author":[{"given":"M. E.","family":"BOON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"BECK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"WIJSMAN\u2010GROOTENDORST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"e_1_2_1_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1992.195"},{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(85)90030-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(86)90063-0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(88)90045-5"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90005-4"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/18.4.775"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870215)59:4<862::AID-CNCR2820590434>3.0.CO;2-P"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1990.tb00348.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91278-3"},{"key":"e_1_2_1_10_2","first-page":"259","article-title":"A comparison of the efficiency of diagnosis of early cervical carcinoma by general practitioners and cytology screening programmes in the Netherlands","volume":"25","author":"Kirk RS","year":"1981","journal-title":"Acta Cytol"},{"key":"e_1_2_1_11_2","volume-title":"The Pap Smear","author":"Boon ME","year":"1993"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90072-A"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6851.449"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089168206800406"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1990.tb00329.x"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2303.1994.tb00529.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2303.1994.tb00529.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T04:48:24Z","timestamp":1698122904000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2303.1994.tb00529.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,4]]}},"alternative-id":["10.1111\/j.1365-2303.1994.tb00529.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2303.1994.tb00529.x","archive":["Portico"],"relation":{},"ISSN":["0956-5507","1365-2303"],"issn-type":[{"value":"0956-5507","type":"print"},{"value":"1365-2303","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,4]]}}}